MetaADEDB 2.0 @ LMMD
lornoxicam
(WLHQHAUOOXYABV-UHFFFAOYSA-N)
Structure
SMILES
Clc1sc2c(c1)S(=O)(=O)N(C(=C2O)C(=O)Nc1ccccn1)C
Type(s)
Approved; Investigational
ATC code(s)
M01AC05
Molecular Formula:
C13H10ClN3O4S2
Molecular Weight:
371.819
Log P:
3.3876
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
136.22
CAS Number(s):
70374-39-9
Synonym(s)
1.
lornoxicam
2.
chlortenoxicam
3.
xefocam
External Link(s)
MeSHC059451
PubChem Compound54690031
BindingDB92331
ChEBI31783
CHEMBLCHEMBL1569487
CHEMBL3188235
DrugBankDB06725
DrugCentral1609
KEGGdr:D01866
ZINC49089868
5318420
100015491
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute glomerulonephritisOFFSIDES
2Alanine Aminotransferase IncreasedOFFSIDES
3AmphetaminesOFFSIDES
4Analgesic asthma syndromeOFFSIDES
5AnorexiaOFFSIDES
6AnosmiaOFFSIDES
7ApathyOFFSIDES
8AppendicitisOFFSIDES
9Arthritis24152722CTD
10Aspiration PneumoniaOFFSIDES
11Blood GlucoseOFFSIDES
12Blood albumin decreasedOFFSIDES
13Blood alkaline phosphatase increasedOFFSIDES
14Blood creatine phosphokinase increasedOFFSIDES
15Blood creatinine decreasedOFFSIDES
16Blood creatinine increasedOFFSIDES
17Blood lactate dehydrogenase increasedOFFSIDES
18Blood pressure inadequately controlledOFFSIDES
19Blood urea increasedOFFSIDES
20Blood uric acidOFFSIDES
21Bulbar palsyOFFSIDES
22CellulitisOFFSIDES
23CholangiolitisOFFSIDES
24Conjunctival depositOFFSIDES
25Cytoreductive SurgeryOFFSIDES
26Deafness NeurosensoryOFFSIDES
27Dental discomfortOFFSIDES
28Depressed Level of ConsciousnessOFFSIDES
29Device related infectionOFFSIDES
30DiarrheaOFFSIDES
31Disseminated Intravascular CoagulationOFFSIDES
32DizzinessOFFSIDES
33Drug ineffectiveOFFSIDES
34DysgeusiaOFFSIDES
35Dysthymic DisorderOFFSIDES
36EczemaOFFSIDES
37EmpyemaOFFSIDES
38EpiglottitisOFFSIDES
39EpilepsyOFFSIDES
40Escherichia sepsisOFFSIDES
41Eye painOFFSIDES
42Forceps deliveryOFFSIDES
43Gamma-Glutamyltransferase IncreasedOFFSIDES
44Gastric ulcerOFFSIDES
45Gastrointestinal amyloidosisOFFSIDES
46Gastrointestinal perforationOFFSIDES
47Gastrointestinal ulcerOFFSIDES
48GlaucomaOFFSIDES
49GlobulinuriaOFFSIDES
50HypoxiaOFFSIDES
51IncoherentOFFSIDES
52Intervertebral disc compressionOFFSIDES
53Intestinal ObstructionOFFSIDES
54IritisOFFSIDES
55LacerationOFFSIDES
56Large intestine perforationOFFSIDES
57Leukopenia neonatalOFFSIDES
58ListeriosisOFFSIDES
59Low Back Pain17163260CTD
60Malignant neoplasm progressionOFFSIDES
61Metastases to abdominal cavityOFFSIDES
62Middle Lobe SyndromeOFFSIDES
63Mucosal erosionOFFSIDES
64Multiple MyelomaOFFSIDES
65Myasthenia GravisOFFSIDES
66Myoglobin blood presentOFFSIDES
67NephrectomyOFFSIDES
68Neutrophil count decreasedOFFSIDES
69OsmophobiaOFFSIDES
70Pain, Postoperative10434236
18027541		CTD
71PemphigusOFFSIDES
72Performance status decreasedOFFSIDES
73PeritonitisOFFSIDES
74PeritonsillitisOFFSIDES
75Pharyngolaryngeal PainOFFSIDES
76PhonophobiaOFFSIDES
77PleurisyOFFSIDES
78Post lumbar puncture syndromeOFFSIDES
79Postoperative Nausea and Vomiting18027541CTD
80Productive CoughOFFSIDES
81Protein total decreasedOFFSIDES
82Psychiatric symptomOFFSIDES
83Retinal Vein OcclusionOFFSIDES
84ScleritisOFFSIDES
85Septic ShockOFFSIDES
86Spinal column stenosisOFFSIDES
87Urine ketone body presentOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.